Date Filed | Type | Description |
08/14/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
07/19/2023 |
S-4/A
| Form S-4/A - Registration of securities, business combinations: [Amend] |
07/18/2023 |
425
| Form 425 - Prospectuses and communications, business combinations: |
07/18/2023 |
8-K/A
| Quarterly results |
07/10/2023 |
425
| Form 425 - Prospectuses and communications, business combinations: |
07/10/2023 |
8-K
| Entry into a Material Definitive Agreement, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submiss... |
07/03/2023 |
425
| Form 425 - Prospectuses and communications, business combinations: |
07/03/2023 |
8-K
| Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits Interactive Data |
07/03/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
06/06/2023 |
S-4
| Form S-4 - Registration of securities, business combinations: |
05/19/2023 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
02/14/2023 |
SC 13G/A
| GOLDMAN SACHS GROUP INC reports a 0% stake in PHOENIX BIOTECH ACQUISITION CORP.* |
02/14/2023 |
SC 13G/A
| Beryl Capital Management LLC reports a 0% stake in Phoenix Biotech Acquisition Corp |
02/14/2023 |
SC 13G/A
| Saba Capital Management, L.P. reports a 6.6% stake in Phoenix Biotech Acquisition Corp |
02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
01/27/2023 |
8-K
| Other Events Interactive Data |
01/25/2023 |
SC 13G/A
| HIGHBRIDGE CAPITAL MANAGEMENT LLC reports a 0% stake in Phoenix Biotech Acquisition Corp. |
12/20/2022 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
12/07/2022 |
425
| Form 425 - Prospectuses and communications, business combinations: |
12/07/2022 |
8-K
| Termination of a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits ...
Docs:
|
"UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Termination Agreement",
"Intrinsic Medicine and Phoenix Biotech Acquisition Corp. Mutually Agree to Terminate Business Combination Agreement Seattle, WA, December 6, 2022 — Intrinsic Medicine, Inc. , a therapeutics company leveraging human milk biology to transform Gut-Brain Axis and inflammatory disorders, and Phoenix Biotech Acquisition Corp. , a special purpose acquisition company sponsored by Phoenix Biotech Sponsor, LLC and formed for the purpose of acquiring or merging with one or more businesses, today announced the mutual termination of their previously announced business combination agreement due to current market conditions. “Intrinsic was encouraged by the positive feedback from prospective investors regarding the attractiveness of our novel and capital-efficient approach to developing transformative ne..." |
|
11/21/2022 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
11/04/2022 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
08/11/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
05/13/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
05/06/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
03/24/2022 |
10-K
| Annual Report for the period ended December 31, 2021 |
02/14/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/11/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/08/2022 |
SC 13G
| PHOENIX BIOTECH SPONSOR, LLC reports a 23% stake in Phoenix Biotech Acquisition Corp. |
11/19/2021 |
10-Q
| Quarterly Report for the period ended September 30, 2021 |
10/22/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
10/18/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
10/18/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
10/15/2021 |
8-K
| Quarterly results |
|